http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022527532-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-223 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-223 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2020-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2022527532-A |
| titleOfInvention | Treatment of AL amyloidosis with melflufen |
| abstract | The present invention relates to melflufen or a salt thereof, or a pharmaceutical preparation containing melflufen or a salt thereof for use in the treatment and / or prevention of immunoglobulin light chain (AL) amyloidosis. The present invention also relates to treatment plans and kits that have been found to be useful in the treatment and / or prevention of AL amyloidosis, as well as methods for the treatment and / or prevention of AL amyloidosis, and the manufacture of therapeutic agents for AL amyloidosis. With respect to the use of melflufen or its salts. |
| priorityDate | 2019-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.